Weber Capital Management, LLC 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-08 12:45 pm Purchase | 2025-03-31 | 13G | Harvard Bioscience, Inc. HBIO | Weber Capital Management, LLC | 3,200,380 7.260% | 683,450 (+27.15%) | Filing |
| 2025-02-10 4:56 pm Purchase | 2024-12-31 | 13G | Harvard Bioscience, Inc. HBIO | Weber Capital Management, LLC | 2,516,930 5.770% | 2,516,930 (New Position) | Filing |